Zydus And Synthon Sign US Ibrance Generic Deal With Potential Exclusivity

Synthon And Pfizer Settle US Patent Infringement Claims Over $3.1bn Palbociclib Brand

 
• By Urtė Fultinavičiūtė
  
Deal handshake agreement document
The paragraph IV certification may grant a six-month market exclusivity • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business